Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'Parkinson''s disease' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2069 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nieuwboer, A; De Weerdt, W; Dom, R; Truyen, M; Janssens, L; Kamsma, Y
      The effect of a home physiotherapy program for persons with Parkinson's disease

      JOURNAL OF REHABILITATION MEDICINE
    2. Sakakibara, R; Shinotoh, H; Uchiyama, T; Sakuma, M; Kashiwado, M; Yoshiyama, M; Hattori, T
      Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease

      AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    3. Sanchez-Pernaute, R; Harvey-White, J; Cunningham, J; Bankiewicz, KS
      Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats

      MOLECULAR THERAPY
    4. Kozlowski, DA; Bremer, E; Redmond, DE; George, D; Larson, B; Bohn, MC
      Quantitative analysis of transgene protein, mRNA, and vector DNA followinginjection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus

      MOLECULAR THERAPY
    5. McCall, WV
      Electroconvulsive thera in the era of modern psychopharmacology

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    6. Becker, G; Berg, D; Lesch, KP; Becker, T
      Basal limbic system alteration in major depression: a hypothesis supportedby transcranial sonography and MRI findings

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    7. Carlsson, A
      A half-century of neurotransmitter research: Impact on neurology and psychiatry (nobel lecture)

      CHEMBIOCHEM
    8. Migliore, L; Scarpato, R; Coppede, F; Petrozzi, L; Bonuccelli, U; Rodilla, V
      Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    9. Goedert, M
      Parkinson's disease and other alpha-synucleinopathies

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    10. Lindvall, O; Hagell, P
      Cell therapy and transplantation in Parkinson's disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    11. Imamura, T; Ishii, K; Hirono, N; Hashimoto, M; Tanimukai, S; Kazui, H; Hanihara, T; Sasaki, M; Mori, E
      Occipital glucose metabolism in dementia with Lewy bodies with and withoutparkinsonism: A study using positron emission tomography

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    12. Vaillancourt, DE; Slifkin, AB; Newell, KM
      Regularity of force tremor in Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    13. Hashimoto, T; Shindo, M; Yanagisawa, N
      Enhanced associated movements in the contralateral limbs elicited by briskvoluntary contraction in choreic disorders

      CLINICAL NEUROPHYSIOLOGY
    14. Wassermann, EM; Lisanby, SH
      Therapeutic application of repetitive transcranial magnetic stimulation: areview

      CLINICAL NEUROPHYSIOLOGY
    15. Bandini, F; Pierantozzi, M; Bodis-Wollner, I
      Parkinson's disease changes the balance of onset and offset visual responses: an evoked potential study

      CLINICAL NEUROPHYSIOLOGY
    16. Chen, R; Kumar, S; Garg, RR; Lang, AE
      Impairment of motor cortex activation and deactivation in Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    17. Cunnington, R; Lalouschek, W; Dirnberger, G; Walla, P; Lindinger, G; Asenbaum, S; Brucke, T; Lang, W
      A medial to lateral shift in pre-movement cortical activity in hemi-Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    18. Ashby, P; Paradiso, G; Saint-Cyr, JA; Chen, R; Lang, AE; Lozano, AM
      Potentials recorded at the scalp by stimulation near the human subthalamicnucleus

      CLINICAL NEUROPHYSIOLOGY
    19. Boylan, LS; Pullman, SL; Lisanby, SH; Spicknall, KE; Sackeim, HA
      Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    20. Muller, T; Benz, S; Bornke, C
      Delay of simple reaction time after levodopa intake

      CLINICAL NEUROPHYSIOLOGY
    21. Hayashi, R; Hashimoto, T; Tada, T; Ikeda, S
      Relation between changes in long-latency stretch reflexes and muscle stiffness in Parkinson's disease - comparison before and after unilateral pallidotomy

      CLINICAL NEUROPHYSIOLOGY
    22. Pezard, L; Jech, R; Ruzicka, E
      Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    23. Mattson, MP; Duan, W; Pedersen, WA; Culmsee, C
      Neurodegenerative disorders and ischemic brain diseases

      APOPTOSIS
    24. Mossner, R; Henneberg, A; Schmitt, A; Syagailo, YV; Grassle, M; Hennig, T; Simantov, R; Gerlach, M; Riederer, P; Lesch, KP
      Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease

      MOLECULAR PSYCHIATRY
    25. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    26. Maddox, WT; Filoteo, JV
      Striatal contributions to category learning: Quantitative modeling of simple linear and complex nonlinear rule learning in patients with Parkinson's disease

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    27. Peavy, GM; Salmon, DP; Bear, I; Paulsen, JS; Cahn, DA; Hofstetter, CR; Kaplan, EF; Delis, DC; Shults, CW
      Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    28. Stout, JC; Rodawalt, WC; Siemers, ER
      Risky decision making in Huntington's disease

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    29. Henderson, L; Harrison, J; Kennard, C
      Selectively impaired reaction time in Parkinson's disease: Persistent absence of simple reaction advantage in a patient with frontal complications

      NEUROCASE
    30. Danysz, W
      Neurotoxicity as a mechanism for neurodegenerative disorders: Basic and clinical aspects - March 16-18th 2001, Pucon, Chile

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Stoessl, AJ
      Antisense strategies for the treatment of neurological disease

      EXPERT OPINION ON THERAPEUTIC PATENTS
    32. Armstrong, RJE; Jain, M; Barker, RA
      Stem cell transplantation as an approach to brain repair

      EXPERT OPINION ON THERAPEUTIC PATENTS
    33. Cadet, JL
      Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice

      PARKINSONISM & RELATED DISORDERS
    34. Fukuda, M; Edwards, C; Eidelberg, D
      Functional brain networks in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    35. Nutt, JG
      Motor fluctuations and dyskinesia in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    36. Tsang, KL; Jiang, H; Ramsden, DB; Ho, SL
      The use of estrogen in the treatment of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    37. Satoh, JI; Kuroda, Y
      Alpha-synuclein expression is up-regulated in NTera2 cells during neuronaldifferentiation but unaffected by exposure to cytokines and neurotrophic factors

      PARKINSONISM & RELATED DISORDERS
    38. Schenkman, M; Zhu, CW; Cutson, TM; Whetten-Goldstein, K
      Longitudinal evaluation of economic and physical impact of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    39. Nogaki, H; Kakinuma, S; Morimatsu, M
      Muscle weakness in Parkinson's disease: a follow-up study

      PARKINSONISM & RELATED DISORDERS
    40. Milanov, I
      A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor

      PARKINSONISM & RELATED DISORDERS
    41. Sanjiv, CC; Schulzer, M; Mak, E; Fleming, J; Martin, WRW; Brown, T; Calne, SM; Tsui, J; Stoessl, AJ; Lee, CS; Calne, DB
      Daytime somnolence in patients with Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    42. Rabinstein, A; Shulman, LM; Weiner, WJ
      Modafinil for the treatment of excessive daytime sleepiness in Parkinson'sdisease: a case report

      PARKINSONISM & RELATED DISORDERS
    43. Manyam, BV; Walters, AS; Keller, IA; Ghobrial, M
      Parkinsonism associated with autosomal dominant bilateral striopallidodentate calcinosis

      PARKINSONISM & RELATED DISORDERS
    44. Kuopio, AM; Marttila, RJ; Helenius, H; Rinne, UK
      Familial occurrence of Parkinson's disease in a community-based case-control study

      PARKINSONISM & RELATED DISORDERS
    45. Pal, PK; Lee, CS; Samii, A; Schulzer, M; Stoessl, AJ; Mak, EK; Wudel, J; Dobko, T; Tsui, JKC
      Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [F-18]-DOPA Ki

      PARKINSONISM & RELATED DISORDERS
    46. Takanashi, M; Mochizuki, H; Yokomizo, K; Hattori, N; Mori, H; Yamamura, Y; Mizuno, Y
      Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP)

      PARKINSONISM & RELATED DISORDERS
    47. Friedman, A; Potulska, A
      Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin

      PARKINSONISM & RELATED DISORDERS
    48. Parent, A; Levesque, M; Parent, M
      A re-evaluation of the current model of the basal ganglia

      PARKINSONISM & RELATED DISORDERS
    49. Isacson, O; Costantini, L; Schumacher, JM; Cicchetti, F; Chung, S; Kim, SK
      Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells

      PARKINSONISM & RELATED DISORDERS
    50. Carvey, PM; McGuire, SO; Ling, ZD
      Neuroprotective effects of D3 dopamine receptor agonists

      PARKINSONISM & RELATED DISORDERS
    51. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    52. Ferre, S; Popoli, P; Gimenez-Llort, L; Rimondini, R; Muller, CE; Stromberg, I; Ogren, O; Fuxe, K
      Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    53. Dugan, LL; Lovett, EG; Quick, KL; Lotharius, J; Lin, TT; O'Malley, KL
      Fullerene-based antioxidants and neurodegenerative disorders

      PARKINSONISM & RELATED DISORDERS
    54. Trojanowski, JQ; Lee, VMY
      Parkinson's disease and related neurodegenerative synucleinopathies linkedto progressive accumulations of synuclein aggregates in brain

      PARKINSONISM & RELATED DISORDERS
    55. Rojo, A; Fontan, A; Mena, MA; Herranz, A; Casado, S; de Yebenes, JG
      Tolcapone increases plasma catecholamine levels in patients with Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    56. Caraceni, T; Musicco, M
      Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study

      PARKINSONISM & RELATED DISORDERS
    57. Weiner, WJ; Factor, SA; Jankovic, J; Hauser, RA; Tetrud, JW; Waters, CH; Shulman, LM; Glassman, PM; Beck, B; Paume, D; Doyle, C
      The long-term safety and efficacy of pramipexole in advanced Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    58. Gimenez-Roldan, S; Mateo, D; Navarro, E; Gines, MM
      Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis

      PARKINSONISM & RELATED DISORDERS
    59. Swerdlow, RH; Parker, WD; Currie, LJ; Bennett, JP; Harrison, MB; Trugman, JM; Wooten, GF
      Gender ratio differences between Parkinson's disease patients and their affected relatives

      PARKINSONISM & RELATED DISORDERS
    60. Giladi, N; Shabtai, H; Rozenberg, E; Shabtai, E
      Gait festination in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    61. Alberts, JL; Adler, CH; Saling, M; Stelmach, GE
      Prehension patterns in restless legs syndrome patients

      PARKINSONISM & RELATED DISORDERS
    62. Polatli, M; Akyol, A; Cildag, O; Bayulkem, K
      Pulmonary function tests in Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    63. Myllyla, VV; Kultalahti, ER; Haapaniemi, H; Leinonen, M
      Twelve-month safety of entacapone in patients with Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    64. Oertel, WH; Stiasny, K
      Differential therapy of nocturnal motor complications: case reports

      EUROPEAN JOURNAL OF NEUROLOGY
    65. Castell, JA; Johnston, BT; Colcher, A; Li, Q; Gideon, RM; Castell, DO
      Manometric abnormalities of the oesophagus in patients with Parkinson's disease

      NEUROGASTROENTEROLOGY AND MOTILITY
    66. Miyamoto, M; Miyamoto, T; Takekawa, H; Kubo, J; Hirata, K
      Parasomnia as an occasion for the diagnosis of Parkinson's disease

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    67. Stefano, GB; Prevot, V; Cadet, P; Dardik, I
      Vascular pulsations stimulating nitric oxide release during cyclic exercise may benefit health: A molecular approach (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    68. Foster, JK
      Selective attention in Alzheimer's disease

      FRONTIERS IN BIOSCIENCE
    69. Kiran, S; Larson, CR
      Effect of duration of pitch-shifted feedback on vocal responses in patients with Parkinson's disease

      JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH
    70. Kleinow, J; Smith, A; Ramig, LO
      Speech motor stability in IPD: Effects of rate and loudness manipulations

      JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH
    71. Lee, PL; Halloran, C; Beutler, E
      Polymorphisms in the transferrin 5 ' flanking region associated with differences in total iron binding capacity: Possible implications in iron homeostasis

      BLOOD CELLS MOLECULES AND DISEASES
    72. Loeffler, DA; Sima, AAF; LeWitt, PA
      Ceruloplasmin immunoreactivity in neurodegenerative disorders

      FREE RADICAL RESEARCH
    73. Erdal, KJ
      Depression and anxiety in persons with Parkinson's disease with and without "on-off" phenomena

      JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS
    74. Higginson, CI; Fields, JA; Koller, WC; Troster, AI
      Questionnaire assessment potentially overestimates anxiety in Parkinson's disease

      JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS
    75. Nakamura, T; Ghilardi, MF; Mentis, M; Dhawan, V; Fukuda, M; Hacking, A; Moeller, JR; Ghez, C; Eidelberg, D
      Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease

      HUMAN BRAIN MAPPING
    76. Bair, JD; Oppelt, TF
      Warfarin and ropinirole interaction

      ANNALS OF PHARMACOTHERAPY
    77. Stromberg, I; Tornqvist, N; Johansson, S; Bygdeman, M; Almqvist, PM
      Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons

      MICROSCOPY RESEARCH AND TECHNIQUE
    78. Furlanut, M; Furlanut, M; Benetello, P
      Monitoring of L-dopa concentrations in Parkinson's disease

      PHARMACOLOGICAL RESEARCH
    79. Rankin, CA; Joazeiro, CAP; Floor, E; Hunter, T
      E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperativeinteraction of RING finger (TRIAD) elements

      JOURNAL OF BIOMEDICAL SCIENCE
    80. Ozsancak, C; Auzou, P; Jan, M; Hannequin, E
      Measurement of voice onset time in dysarthric patients: Methodological considerations

      FOLIA PHONIATRICA ET LOGOPAEDICA
    81. West, AB; Zimprich, A; Lockhart, PJ; Farrer, M; Singleton, A; Holtom, B; Lincoln, S; Hofer, A; Hill, L; Muller-Myhsok, B; Wszolek, ZK; Hardy, J; Gasser, T
      Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes

      EUROPEAN JOURNAL OF HUMAN GENETICS
    82. Jacobs, H; Latza, U; Vieregge, A; Vieregge, P
      Aptitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing

      GENETIC COUNSELING
    83. Thobois, S; Guillouet, S; Broussolle, E
      Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    84. Almirall, H; Bautista, V; Sanchez-Bahillo, A; Trinidad-Herrero, M
      Ultradian and circadian body temperature and activity rhythms in chronic MPTP treated monkeys

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    85. Borlongan, CV; Zhou, FC; Hayashi, T; Su, TP; Hoffer, BJ; Wang, Y
      Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats

      NEUROBIOLOGY OF DISEASE
    86. Johansson, PA; Andersson, M; Andersson, KE; Cenci, MA
      Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

      NEUROBIOLOGY OF DISEASE
    87. Kung, HF
      Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent

      NUCLEAR MEDICINE AND BIOLOGY
    88. Liss, B; Roeper, J
      Molecular physiology of neuronal K-ATP channels

      MOLECULAR MEMBRANE BIOLOGY
    89. Koopmans, J; HogenEsch, I; Copray, S; Middel, B; van Dijk, H; Go, KG; Staal, M
      Cryopreservation of porcine fetal ventral mesencephalic tissue for intrastriatal transplantation in Parkinson's disease

      CELL TRANSPLANTATION
    90. Date, I; Shingo, T; Yoshida, H; Fujiwara, K; Kobayashi, K; Takeuchi, A; Ohmoto, T
      Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats

      CELL TRANSPLANTATION
    91. Larsson, LC; Anderson, P; Widner, H; Korsgren, O
      Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion

      CELL TRANSPLANTATION
    92. Brevig, T; Meyer, M; Kristensen, T; Zimmer, J
      Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-gal antibodies and complement is not toxic for the dopaminergicneurons

      CELL TRANSPLANTATION
    93. Borlongan, CV; Su, TP; Wang, Y
      Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells

      CELL TRANSPLANTATION
    94. Katsarou, Z; Bostantjopoulou, S; Peto, V; Alevriadou, A; Kiosseoglou, G
      Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39)

      QUALITY OF LIFE RESEARCH
    95. Farin, FM; Janssen, P; Quigley, S; Abbott, D; Hassett, C; Smith-Weller, T; Franklin, GM; Swanson, PD; Longstreth, WT; Omiecinski, CJ; Checkoway, H
      Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease

      PHARMACOGENETICS
    96. Marsden, J; Limousin-Dowsey, P; Fraix, V; Pollak, P; Odin, P; Brown, P
      Intermuscular coherence in Parkinson's disease: effects of subthalamic nucleus stimulation

      NEUROREPORT
    97. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
      Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?

      NEUROREPORT
    98. Ferger, B; Rose, S; Jenner, A; Halliwell, B; Jenner, P
      6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum

      NEUROREPORT
    99. Hartman, VN; Miller, MA; Clayton, DF; Liu, WC; Kroodsma, DE; Brenowitz, EA
      Testosterone regulates alpha-synuclein mRNA in the avian song system

      NEUROREPORT
    100. Campbell, BM; Walker, PD
      MK-801 prevents dopamine DI but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression

      NEUROREPORT


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:14:05